Patent · US Active

Tetrabenazine transdermal delivery device

US12144899B2 · kind B2 · utility

0Cited by
10References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2019
Grant dateNov 19, 2024
Priority date
Expiry dateMar 1, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are transdermal delivery devices comprising tetrabenazine, a deuterated tetrabenazine, or a combination thereof. Also provided herein are pharmaceutical compositions, such as adhesive compositions, comprising tetrabenazine, a deuterated tetrabenazine, or a combination thereof, for example, homogenously dispersed in an adhesive, such as a pressure sensitive adhesive. Further provided herein are methods of using the transdermal delivery devices or pharmaceutical compositions, for example, for treating a hyperkinetic movement disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.